Inhibitors of arachidonate metabolism and effects on PAF production.
Winkler
J D
JD
Division of Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406, USA.
Sung
C M
CM
Marshall
L A
LA
Chilton
F H
FH
D000217:Acyltransferases / Q000037:antagonists & inhibitors*; D000818:Animals; D016718:Arachidonic Acid / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D001557:Benzenesulfonates / Q000494:pharmacology; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D008407:Mast Cells / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D008808:Mice, Inbred CBA; D009000:Monocytes / Q000187:drug effects / Q000378:metabolism; D009943:Organophosphorus Compounds / Q000494:pharmacology; D010972:Platelet Activating Factor / Q000096:biosynthesis*; D014508:Urea / Q000031:analogs & derivatives / Q000494:pharmacology
C093344:2-(2-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)-4-(trifluoromethyl)phenoxy)-4,5-dichlorobenzenesulfonic acid; D001557:Benzenesulfonates; D004791:Enzyme Inhibitors; D007093:Imidazoles; D009943:Organophosphorus Compounds; D010972:Platelet Activating Factor; C093303:SK&F 98625; D016718:Arachidonic Acid; D014508:Urea; D000217:Acyltransferases; C039766:arachidonyl transacylase